ARTICLE SYNOPSIS...Abbott Laboratories (ABT) generates the highest percentage of its revenue through pharmaceuticals, at around 62%.
AUTHOR: Koos van der MerweDATE: MAY 2013
ARTICLE SYNOPSIS...Core Laboratories (CLB) seems to have self-destructed and busted its bullish trend but it may be signaling to go long once again.
AUTHOR: Billy WilliamsDATE: JUN 2014
ARTICLE SYNOPSIS...After a long corrective period, Forest Laboratories is undergoing a bullish breakout.
AUTHOR: Chaitali MohileDATE: JUN 2011
ARTICLE SYNOPSIS...With the Obama health plan coming into play in spite of opposition, is it worthwhile to invest in pharmaceutical companies?
AUTHOR: Koos van der MerweDATE: JAN 2011